World Journal of Dentistry

Register      Login

VOLUME 13 , ISSUE 5 ( September-October, 2022 ) > List of Articles


Oral Manifestations in Hospitalized COVID Patients

Claudia Ferdeghini, Luca Mirabelli, Edoardo Bianco, Subhalakshmi Hari, Marcello Maddalone

Keywords : Ageusia, COVID-19, Oral manifestations, White tongue, Xerostomia

Citation Information : Ferdeghini C, Mirabelli L, Bianco E, Hari S, Maddalone M. Oral Manifestations in Hospitalized COVID Patients. World J Dent 2022; 13 (5):434-440.

DOI: 10.5005/jp-journals-10015-2082

License: CC BY-NC 4.0

Published Online: 22-07-2022

Copyright Statement:  Copyright © 2022; The Author(s).


Aim: Evaluation of oral lesions in COVID-hospitalized patients, analyzing the potential etiopathogenetic mechanisms. Materials and methods: We evaluated a total of 58 hospitalized COVID patients in the time span from April 2021 to May 2021. The group analyzed consists of 38 male patients (66%) and 20 female patients (34%), aged between 22 and 92, with a preponderance of 60–80 years. All patients underwent an oral evaluation in order to detect the various oral manifestations; moreover, the onset time of these lesions has been correlated with the time of manifestation of the general symptoms of COVID infection. Results: Xerostomia has been the most frequent oral manifestation detected (30 patients, 51.7% of the sample), followed by ageusia (16 patients, 27.6%), and white tongue (13 patients, 22.4%). Other oral manifestations observed were aphthous lesions, fissured tongue, metallic taste, tingling in the lip and chin, and burning mouth syndrome. Conclusion: Our findings show a significant correlation between the oral manifestations and the burst of viral replication phase in COVID patients. Clinical significance: Awareness of the possible oral manifestations of COVID infection is important to conduct a correct diagnosis in oral pathology.

PDF Share
  1. Woo PC, Lau SK, Lam CS, et al. Discovery of seven novel mammalian and avian coronaviruses in the genus deltacoronavirus supports bat coronaviruses as the gene source of alphacoronavirus and betacoronavirus and avian coronaviruses as the gene source of gammacoronavirus and deltacoronavirus. J Virol 2012;86(7): 3995–4008. DOI: 10.1128/JVI.06540-11
  2. Zhu Z, Lian X, Su X, et al. From SARS and MERS to COVID-19: a brief summary and comparison of severe acute respiratory infections caused by three highly pathogenic human coronaviruses. Respir Res 2020;21(1):224. DOI: 10.1186/s12931
  3. Shereen MA, Khan S, Kazmi A, et al. COVID-19 infection: origin, transmission, and characteristics of human coronaviruses. J Adv Res 2020;24:91–98. DOI: 10.1016/j.jare.2020.03.005
  4. de Wit E, van Doremalen N, Falzarano D, et al. SARS and MERS: recent insights into emerging coronaviruses. Nat Rev Microbiol 2016;14(8):523–534. DOI: 10.1038/nrmicro.2016.81
  5. Wu F, Zhao S, Yu B, et al. A new coronavirus associated with human respiratory disease in China. Nature 2020;579(7798):265–269. DOI: 10.1038/s41586-020-2008-3
  6. Zhou P, Yang XL, Wang XG, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020;579(7798): 270–273. DOI: 10.1038/s41586-020-2012-7
  7. Yang J, Petitjean SJL, Koehler M, et al. Molecular interaction and inhibition of SARS-CoV-2 binding to the ACE2 receptor. Nat Commun 2020;11(1):4541. DOI: 10.1038/s41467-020-18319-6
  8. Mishra SK, Tripathi T. One year update on the COVID-19 pandemic: where are we now? Acta Trop 2021;214:105778. DOI: 10.1016/j.actatropica.2020.105778
  9. Cascella M, Rajnik M, Aleem A, et al. Features, evaluation, and treatment of coronavirus (COVID-19). In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021. PMID:32150360.
  10. Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020;382(18):1708–1720. DOI: 10.1056/NEJMoa2002032
  11. Kuba K, Imai Y, Rao S, et al. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nat Med 2005;11(8):875–879. DOI: 10.1038/nm1267
  12. Eskian M, Rezaei N. Clinical manifestations of COVID-19. Adv Exp Med Biol 2021;1318:179–196. DOI: 10.1007/978-3-030-63761-3_11
  13. Cole-Jeffrey CT, Liu M, Katovich MJ, et al. ACE2 and microbiota: emerging targets for cardiopulmonary disease therapy. J Cardiovasc Pharmacol 2015;66(6):540–550. DOI: 10.1097/FJC.0000000000000307
  14. Su H, Yang M, Wan C, et al. Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China. Kidney Int 2020;98(1):219–227. DOI: 10.1016/j.kint.2020.04.003
  15. Recalcati S. Cutaneous manifestations in COVID-19: a first perspective. J Eur Acad Dermatol Venereol 2020;34(5):e212–e213. DOI: 10.1111/jdv.16387
  16. Drożdżal S, Rosik J, Lechowicz K, et al. COVID-19: pain management in patients with SARS-CoV-2 infection-molecular mechanisms, challenges, and perspectives. Brain Sci 2020;10(7):465. DOI: 10.3390/brainsci10070465
  17. Mehta OP, Bhandari P, Raut A, et al. Coronavirus disease (COVID-19): comprehensive review of clinical presentation. Front Public Health 2021;8:582932. DOI: 10.3389/fpubh.2020.582932
  18. Sakaguchi W, Kubota N, Shimizu T, et al. Existence of SARS-CoV-2 entry molecules in the oral cavity. Int J Mol Sci 2020;21(17):6000. DOI: 10.3390/ijms21176000
  19. Bianco E, Calvelli C, Citterio CL, et al. Evaluation with micro-CT of the canal seal made with two different bioceramic cements: GuttaFlow bioseal and BioRoot RCS. J Contemp Dent Pract 2020;21(4):359–366. DOI: 10.5005/jp-journals-10024-2816
  20. Bianco E, Nanussi A, Bellotti D, et al. Clinical and functional analyses of the musculoskeletal balance with oral electromyography and stabilometric platform in athletes of different disciplines. World J Dent 2020;11(3):166–171. DOI: 10.5005/jp-journals-10015-1722
  21. Cortese M, Pigato G, Casiraghi G, et al. Evaluation of the oropharyngeal airway space in class II malocclusion treated with mandibular activator: a retrospective study. J Contemp Dent Pract 2020;21(6):666–672. DOI: 10.5005/jp-journals-10024-2856
  22. Maddalone M, Bianco E, Nanussi A, et al. Treatment of temporomandibular disorders of muscular origin with a silicon oral device (Alifix®): electromyographic analysis. J Contemp Dent Pract 2019;20(12):1367–1374. DOI: 10.5005/jp-journals-10024-2704
  23. Maddalone M, Breschigliaro S, Mirabelli L, et al. Radiographic evaluation of the bone remodeling on tilted osseointegrated implants: follow-up at 1 year. J Contemp Dent Pract 2020;21(4): 463–470. PMID: 32584287. DOI: 10.5005/jp-journals-10024-2799
  24. Maddalone M, Nanussi A, Varisco M, et al. Electromyographic evaluation of masticatory muscles in a young patient with crossbite treated with rapid palatal expander: a case report. J Contemp Dent Pract 2020;21(11):1279–1283. DOI: 10.5005/jp-journals-10024-2782
  25. Chaux-Bodard AG, Deneuve S, Desoutter A. Oral manifestation of COVID-19 as an inaugural symptom? J Oral Med Oral Surg 2020;26:18. DOI: 10.1051/mbcb/2020011
  26. Aziz M, Perisetti A, Lee-Smith WM, et al. Taste changes (dysgeusia) in COVID-19: a systematic review and meta-analysis. Gastroenterology 2020;159(3):1132–1133. DOI: 10.1053/j.gastro.2020.05.003
  27. Amorim Dos Santos J, Normando AGC, Carvalho da Silva RL, et al. Oral manifestations in patients with COVID-19: a living systematic review. J Dent Res 2021;100(2):141–154. DOI: 10.1177/0022034520957289
  28. Cirillo N, Bizzoca ME, Lo Muzio E, et al. Gustatory dysfunction in COVID-19 patients: a rapid systematic review on 27,687 cases. Acta Odontol Scand 2021;79(6):418–425. DOI: 10.1080/00016357.2020.1869828
  29. Xu H, Zhong L, Deng J, et al. High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. Int J Oral Sci 2020;12(1):8. DOI: 10.1038/s41368-020-0074-x
  30. Sato T, Ueha R, Goto T, et al. Expression of ACE2 and TMPRSS2 proteins in the upper and lower aerodigestive tracts of rats: implications on COVID 19 infections. Laryngoscope 2021;131(3):E932–E939. DOI: 10.1002/lary.29132
  31. Tsuchiya H. Oral symptoms associated with COVID-19 and their pathogenic mechanisms: a literature review. Dent J (Basel) 2021;9(3):32. DOI: 10.3390/dj9030032
  32. Wang Z, Zhou J, Marshall B, et al. SARS-CoV-2 receptor ACE2 is enriched in a subpopulation of mouse tongue epithelial cells in nongustatory papillae but not in taste buds or embryonic oral epithelium. ACS Pharmacol Transl Sci 2020;3(4):749–758. DOI: 10.1021/acsptsci.0c00062
  33. Lahiri D, Ardila A. COVID-19 pandemic: a neurological perspective. Cureus 2020;12(4):e7889. DOI: 10.7759/cureus.7889
  34. Fathi Y, Hoseini EG, Atoof F, et al. Xerostomia (dry mouth) in patients with COVID-19: a case series. Future Virol 2021;16(5):315–319. DOI: 10.2217/fvl-2020-0334
  35. Freni F, Meduri A, Gazia F, et al. Symptomatology in head and neck district in coronavirus disease (COVID-19): a possible neuroinvasive action of SARS-CoV-2. Am J Otolaryngol 2020;41(5):102612. DOI: 10.1016/j.amjoto.2020.102612
  36. Fantozzi PJ, Pampena E, Di Vanna D, et al. Xerostomia, gustatory and olfactory dysfunctions in patients with COVID-19. Am J Otolaryngol 2020;41(6):102721. DOI: 10.1016/j.amjoto.2020.102721. PMID: 32977063; PMCID: PMC7482593.
  37. Dziedzic A, Wojtyczka R. The impact of coronavirus infectious disease 19 (COVID-19) on oral health. Oral Dis 2020;27(Suppl 3):703–706. DOI: 10.1111/odi.13359
  38. Favia G, Tempesta A, Barile G, et al. COVID-19 symptomatic patients with oral lesions: clinical and histopathological study on 123 cases of the University Hospital Policlinic of Bari with a purpose of a new classification. J Clin Med 2021;10(4):757. DOI: 10.3390/jcm10040757
  39. Nuno-Gonzalez A, Martin-Carrillo P, Magaletsky K, et al. Prevalence of mucocutaneous manifestations in 666 patients with COVID-19 in a field hospital in Spain: oral and palmoplantar findings. Br J Dermatol 2021;184(1):184–185. DOI: 10.1111/bjd.19564
  40. Brandão TB, Gueiros LA, Melo TS, et al. Oral lesions in patients with SARS-CoV-2 infection: could the oral cavity be a target organ? Oral Surg Oral Med Oral Pathol Oral Radiol 2021;131(2):e45–e51. DOI: 10.1016/j.oooo.2020.07.014
  41. Mahmoud MM, Abuohashish HM, Khairy DA, et al. Pathogenesis of dysgeusia in COVID-19 patients: a scoping review. Eur Rev Med Pharmacol Sci 2021;25(2):1114–1134. DOI: 10.26355/eurrev_202101_24683
  42. Parma V, Ohla K, Veldhuizen MG, et al. More than smell-COVID-19 is associated with severe impairment of smell, taste, and chemesthesis. Chem Senses 2020;45(7):609–622. DOI: 10.1093/chemse/bjaa041
  43. Pang W, Zhang D, Zhang J, et al. Tongue features of patients with coronavirus disease 2019: a retrospective cross-sectional study. Integr Med Res 2020;9(3):100493. DOI: 10.1016/j.imr.2020.100493
  44. Riad A, Gomaa E, Hockova B, et al. Oral candidiasis of COVID-19 patients: case report and review of evidence. J Cosmet Dermatol 2021;20(6):1580–1584. DOI: 10.1111/jocd.14066
  45. Gherlone EF, Polizzi E, Tetè G, et al. Frequent and persistent salivary gland ectasia and oral disease after COVID-19. J Dent Res 2021;100(5):464–471. DOI: 10.1177/0022034521997112
  46. Sinjari B, D'Ardes D, Santilli M, et al. SARS-CoV-2 and oral manifestation: an observational, human study. J Clin Med 2020;9(10):3218. DOI: 10.3390/jcm9103218. PMID: 33036482; PMCID: PMC7600761.
  47. Scala A, Checchi L, Montevecchi M, et al. Update on burning mouth syndrome: overview and patient management. Crit Rev Oral Biol Med 2003;14(4):275–291. DOI: 10.1177/154411130301400405
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.